Evidence map›Paper›PMID 39769463›Full record

ArticleInternational journal of molecular sciences2024

Conjugated Human Serum Albumin/Gold-Silica Nanoparticles as Multifunctional Carrier of a Chemotherapeutic Drug.

Elena Morrone, Lucie Sancey, Fabien Dalonneau, Loredana Ricciardi, Massimo La Deda

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elena MorroneDepartment of Chemistry, Biology and Biotechnology, University of Perugia, 06123 Perugia, Italy.
Lucie SanceyUniversité Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences (IAB), 38000 Grenoble, France.ORCID 0000-0002-0084-3775
Fabien DalonneauUniversité Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences (IAB), 38000 Grenoble, France.
Loredana RicciardiCNR-NANOTEC Institute of Nanotechnology, National Research Council, 87036 Rende, Italy.ORCID 0000-0002-2724-9952
Massimo La DedaDepartment of Chemistry and Chemical Technologies, University of Calabria, 87036 Rende, Italy.ORCID 0000-0002-8611-5575

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the design and development of a novel multifunctional nanostructure, RB-AuSiO

Indexed as

DoxorubicinDrug CarriersGoldSerum Albumin, HumanSilicon DioxideAntineoplastic AgentsCell Line, TumorHumansMetal NanoparticlesNanoparticlesPhotochemotherapyPhotosensitizing AgentsRose BengalAntineoplastic AgentsDoxorubicinDrug CarriersGoldPhotosensitizing AgentsRose BengalSerum Albumin, HumanSilicon Dioxidechemotherapyhuman serum albuminmultifunctional nanoplatformsphototherapytumor targeting

Identifiers

PMID39769463
PMCPMC11678608

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.